LA JOLLA, Calif., Dec. 23, 2025 (GLOBE NEWSWIRE) -- Singlera Genomics, a company focused on the development and application ...

Singlera Genomics, a company focused on the application of novel DNA methylation technologies to genetic diagnosis, with ...

Shares of biotech company 10x Genomics (NASDAQ:TXG) jumped 4.8% in the morning session after Canaccord Genuity maintained its ...

After taking a shot at becoming a neuroscience biotech, buzzy Bay Area AI outfit Verge Genomics is dropping its only clinical ...

Wobble Genomics, a biotechnology company focused on improving cancer outcomes through better diagnosis and therapy selection, will present new data at the 2025 San Antonio Breast Cancer Symposium ...

Vossman discusses the genomics landscape, as well as next-generation sequencing (or NGS), and the Model Project, a ...

Cofactor Genomics, a commercial-stage diagnostics company transforming precision oncology through RNA-based predictive tests, today announced strategic investments from Labcorp and Ascension Ventures.

O 15, 2025, Barclays analyst Luke Sergott raised the price target for TXG from $17 to $22 while maintaining an Overweight ...

Tempus AI TEM reported non-GAAP profit in the third quarter of 2025 as genomics testing and data services gained momentum.

Genomics drives climate resilience by revealing microbial impacts on Portuguese crops and supporting Amazonian pirarucu ...

Helio Genomics and LiverRight have entered into a partnership designed to improve access to early liver cancer detection in the US.